For instance, although endoscopy remains the gold standard for the diagnosis and monitoring of IBD, the use of molecular biomarkers in clinical practice, including fecal calprotectin [23], serum C-reactive protein (CRP) [24], and serum autoantibodies, has been extremely important and supportive. The gene discussed is CRP; the disease is inflammatory bowel disease.